Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Glucose-Dependent Insulinotropic Polypeptide Prevents the Progression of Macrophage-Driven Atherosclerosis in Diabetic Apolipoprotein E-Null Mice

Open access

Abstract

AIM: We recently reported that glucose-dependent insulinotropic polypeptide (GIP) prevents the development of atherosclerosis in apolipoprotein E-null (Apoe(-/-)) mice. GIP receptors (GIPRs) are found to be severely down-regulated in diabetic animals. We examined whether GIP can exert anti-atherogenic effects in diabetes. METHODS: Nondiabetic Apoe(-/-) mice, streptozotocin-induced diabetic Apoe(-/-) mice, and db/db mice were administered GIP (25 nmol/kg/day) or saline (vehicle) through osmotic mini-pumps for 4 weeks. The animals were assessed for aortic atherosclerosis and for oxidized low-density lipoprotein-induced foam cell formation in exudate peritoneal macrophages. RESULTS: Diabetic Apoe(-/-) mice of 21 weeks of age exhibited more advanced atherosclerosis than nondiabetic Apoe(-/-) mice of the same age. GIP infusion in diabetic Apoe(-/-) mice increased plasma total GIP levels by 4-fold without improving plasma insulin, glucose, or lipid profiles. GIP infusion significantly suppressed macrophage-driven atherosclerotic lesions, but this effect was abolished by co-infusions with [Pro(3)]GIP, a GIPR antagonist. Foam cell formation was stimulated by 3-fold in diabetic Apoe(-/-) mice compared with their nondiabetic counterparts, but this effect was halved by GIP infusion. GIP infusion also attenuated the foam cell formation in db/db mice. In vitro treatment with GIP (1 nM) reduced foam cell formation by 15% in macrophages from diabetic Apoe(-/-) mice, and this attenuating effect was weaker than that attained by the same treatment of macrophages from nondiabetic counterparts (35%). While GIPR expression was reduced by only about a half in macrophages from diabetic mice, it was reduced much more dramatically in pancreatic islets from the same animals. Incubation with high glucose (500 mg/dl) for 9-10 days markedly reduced GIPR expression in pancreatic islet cells, but not in macrophages. CONCLUSIONS: Long-term infusion of GIP conferred significant anti-atherogenic effects in diabetic mice even though the GIPR expression in macrophages was mildly down-regulated in the diabetic state.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0035683

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Suppressive effects of GIP on the progression of atherosclerotic lesions in diabetic Apoe −/− mice. Thirty-five mice at 15 weeks of age were made diabetes by peritoneal injection of STZ (50 mg/kg/day) for 5 days and 14 mice were untreated. The 17-week-old diabetic Apoe −/− mice were infused for 4 weeks with vehicle (control), GIP (25 nmol/kg/day), or GIP+[Pro3]GIP (both 25 nmol/kg/day) by osmotic mini-pumps. The aortic surface was stained with oil red O. Cross-sections of the aortic root were stained with oil red O or anti-MOMA-2 antibody. Hematoxylin was used for nuclear staining. The areas occupied by atherosclerotic lesions and by macrophage infiltration in the aortic wall were determined.
Figure 1 Suppressive effects of GIP on the progression of atherosclerotic lesions in diabetic Apoe −/− mice. Thirty-five mice at 15 weeks of age were made diabetes by peritoneal injection of STZ (50 mg/kg/day) for 5 days and 14 mice were untreated. The 17-week-old diabetic Apoe −/− mice were infused for 4 weeks with vehicle (control), GIP (25 nmol/kg/day), or GIP+[Pro3]GIP (both 25 nmol/kg/day) by osmotic mini-pumps. The aortic surface was stained with oil red O. Cross-sections of the aortic root were stained with oil red O or anti-MOMA-2 antibody. Hematoxylin was used for nuclear staining. The areas occupied by atherosclerotic lesions and by macrophage infiltration in the aortic wall were determined.CC BY · PubMed Central
Figure 2 Foam cell formation in exudate peritoneal mouse macrophages. A, 12 Apoe −/− mice at 15 weeks of age were made diabetes by peritoneal injection of STZ (50 mg/kg/day) for 5 days and 6 Apoe −/− mice were untreated. The 17-week-old diabetic Apoe −/− mice were infused for 4 weeks with vehicle, GIP (25 nmol/kg/day), or GIP+[Pro3]GIP (both 25 nmol/kg/day) by osmotic mini-pumps. B, 6 db/misty mice and 6 db/db mice at 8 weeks of age were started to be infused with saline and 6 db/db mice were ifused with GIP (25 nmol/kg/day). Four weeks after infusions, exudate peritoneal macrophages were obtained from these mice by intraperitoneal injection of thioglycolate, and incubated with oxLDL (10 µg/ml) for 18 hours. Foam cell formation was evaluated by oxLDL-induced CE accumulation in macrophages. Assays were performed in duplicate or single. 1 fold = 17.5±1.0 nmol/mg cell protein (A) and 14.7±1.2 nmol/mg cell protein (B).
Figure 2 Foam cell formation in exudate peritoneal mouse macrophages. A, 12 Apoe −/− mice at 15 weeks of age were made diabetes by peritoneal injection of STZ (50 mg/kg/day) for 5 days and 6 Apoe −/− mice were untreated. The 17-week-old diabetic Apoe −/− mice were infused for 4 weeks with vehicle, GIP (25 nmol/kg/day), or GIP+[Pro3]GIP (both 25 nmol/kg/day) by osmotic mini-pumps. B, 6 db/misty mice and 6 db/db mice at 8 weeks of age were started to be infused with saline and 6 db/db mice were ifused with GIP (25 nmol/kg/day). Four weeks after infusions, exudate peritoneal macrophages were obtained from these mice by intraperitoneal injection of thioglycolate, and incubated with oxLDL (10 µg/ml) for 18 hours. Foam cell formation was evaluated by oxLDL-induced CE accumulation in macrophages. Assays were performed in duplicate or single. 1 fold = 17.5±1.0 nmol/mg cell protein (A) and 14.7±1.2 nmol/mg cell protein (B).CC BY · PubMed Central
Figure 3 Changes in GIPR mRNA levels in macrophages and pancreatic β-cells ex vivo and in vitro. A, Exudate peritoneal macrophages were obtained from 5 nondiabetic mice and 5 STZ-induced diabetic Apoe −/− mice by intraperitoneal injection of thioglycolate. B, Exudate peritoneal macrophages were obtained from 3 db/misty mice and 3 db/db mice at 12 weeks of age. C, THP-1 macrophages (human), J774A1 macrophages (mouse), and 1.2B4 pancreatic β-cells (human) were incubated with RPMI-1640 containing high glucose (500 mg/dl) for 9–10 days. Changes in GIPR mRNA levels were determined by real-time RT-PCR. Three independent experiments were performed. *P<0.05, **P<0.01 vs. each baseline of day 0.
Figure 3 Changes in GIPR mRNA levels in macrophages and pancreatic β-cells ex vivo and in vitro. A, Exudate peritoneal macrophages were obtained from 5 nondiabetic mice and 5 STZ-induced diabetic Apoe −/− mice by intraperitoneal injection of thioglycolate. B, Exudate peritoneal macrophages were obtained from 3 db/misty mice and 3 db/db mice at 12 weeks of age. C, THP-1 macrophages (human), J774A1 macrophages (mouse), and 1.2B4 pancreatic β-cells (human) were incubated with RPMI-1640 containing high glucose (500 mg/dl) for 9–10 days. Changes in GIPR mRNA levels were determined by real-time RT-PCR. Three independent experiments were performed. *P<0.05, **P<0.01 vs. each baseline of day 0.CC BY · PubMed Central
Figure 4 Expression of GIPR in exudate peritoneal macrophages from nondiabetic and diabetic Apoe −/− mice. GIPR was stained with goat polyclonal anti-GIPR antibody followed by anti-goat Alexa Fluor 568. Phalloidin/DAPI staining shows F-actin cytoskeleton and nuclear morphology of mouse macrophages. These images were merged. Representative results are shown.
Figure 4 Expression of GIPR in exudate peritoneal macrophages from nondiabetic and diabetic Apoe −/− mice. GIPR was stained with goat polyclonal anti-GIPR antibody followed by anti-goat Alexa Fluor 568. Phalloidin/DAPI staining shows F-actin cytoskeleton and nuclear morphology of mouse macrophages. These images were merged. Representative results are shown.CC BY · PubMed Central
Figure 5 Expression of GIPR in exudate peritoneal macrophages from db/misty and db/db mice. GIPR was stained with goat polyclonal anti-GIPR antibody followed by anti-goat Alexa Fluor 568. Phalloidin/DAPI staining shows F-actin cytoskeleton and nuclear morphology of mouse macrophages. These images were merged. Representative results are shown.
Figure 5 Expression of GIPR in exudate peritoneal macrophages from db/misty and db/db mice. GIPR was stained with goat polyclonal anti-GIPR antibody followed by anti-goat Alexa Fluor 568. Phalloidin/DAPI staining shows F-actin cytoskeleton and nuclear morphology of mouse macrophages. These images were merged. Representative results are shown.CC BY · PubMed Central
Figure 6 Expression of GIPR in pancreatic islets from db/misty and db/db mice. GIPR was stained with goat polyclonal anti-GIPR antibody. Hematoxylin was used for nuclear staining. Representative results are shown.
Figure 6 Expression of GIPR in pancreatic islets from db/misty and db/db mice. GIPR was stained with goat polyclonal anti-GIPR antibody. Hematoxylin was used for nuclear staining. Representative results are shown.CC BY · PubMed Central
Figure 7 In vitro suppressive effects of GIP on foam cell formation in exudate peritoneal macrophages from nondiabetic and diabetic Apoe −/− mice. Exudate peritoneal macrophages were obtained from 6 nondiabetic Apoe −/− mice (A) and 6 STZ-induced diabetic Apoe −/− mice (B) by intraperitoneal injection of thioglycolate, and were incubated with or without GIP (1 nM) for 24 hours followed by addition of oxLDL (10 µg/ml) for 18 hours. Foam cell formation was evaluated by oxLDL-induced CE accumulation in macrophages. Assays were performed in duplicate. 1 fold = 15.6±1.5 nmol/mg cell protein (A) and 13.8±1.0 nmol/mg cell protein (B).
Figure 7 In vitro suppressive effects of GIP on foam cell formation in exudate peritoneal macrophages from nondiabetic and diabetic Apoe −/− mice. Exudate peritoneal macrophages were obtained from 6 nondiabetic Apoe −/− mice (A) and 6 STZ-induced diabetic Apoe −/− mice (B) by intraperitoneal injection of thioglycolate, and were incubated with or without GIP (1 nM) for 24 hours followed by addition of oxLDL (10 µg/ml) for 18 hours. Foam cell formation was evaluated by oxLDL-induced CE accumulation in macrophages. Assays were performed in duplicate. 1 fold = 15.6±1.5 nmol/mg cell protein (A) and 13.8±1.0 nmol/mg cell protein (B).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 96

Metadata

Authors
Nogi, Y., Nagashima, M., Terasaki, M., Nohtomi, K., Watanabe, T., & Hirano, T.
Affiliations
  • SHOWA Medical University (JP)
  • Tokyo University of Pharmacy and Life Sciences (JP)
Corresponding author
Hirano, Tsutomu
Venue
PLoS ONE
Published
2012-04-20
Volume
7
Issue
4
Pages
e35683
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2080103614
Cited by
96
References
26
Citations by year
2026: 12 · 2025: 8 · 2024: 7 · 2023: 7 · 2022: 12 · 2021: 8 · 2020: 4 · 2019: 5 · 2018: 3 · 2017: 5 · 2016: 7 · 2015: 8 · 2014: 2 · 2013: 6 · 2012: 2
FWCI
2.48
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Japan Society for the Promotion of Science (22590831)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords
glucose-dependent insulinotropic polypeptide, atherosclerosis, diabetes mellitus, macrophages, foam cell formation, apolipoprotein E-null mice, GIP receptor, oxidized LDL, pancreatic islets, streptozotocin-induced diabetes, db/db mice, antiatherogenic effects
MeSH terms
Animals, Aorta, Apolipoproteins E, Ascitic Fluid, Cells, Cultured, Diabetes Mellitus, Experimental, Foam Cells, Gastric Inhibitory Polypeptide, Islets of Langerhans, Receptors, Gastrointestinal Hormone, Down-Regulation, Gene Expression, Macrophages, Peritoneal, Mice, Knockout, Atherosclerosis, Mice, Gene Knockout Techniques, Plaque, Atherosclerotic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glucose-Dependent Insulinotropic Polypeptide Prevents the Progression of Macrophage-Driven Atherosclerosis in Diabetic Apolipoprotein E-Null Mice. https://app.cochat.ai/papers/10.1371/journal.pone.0035683
The paper
Nogi, Y., Nagashima, M., Terasaki, M., Nohtomi, K., Watanabe, T., & Hirano, T. (2012). Glucose-Dependent Insulinotropic Polypeptide Prevents the Progression of Macrophage-Driven Atherosclerosis in Diabetic Apolipoprotein E-Null Mice. PLoS ONE. https://doi.org/10.1371/journal.pone.0035683

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.